Erica S Spatz, Michael Gottlieb, Lauren E Wisk, Jill Anderson, Anna Marie Chang, Nicole L Gentile, Mandy J Hill, Ryan M Huebinger, Ahamed H Idris, Jeremiah Kinsman, Katherine Koo, Shu-Xia Li, Samuel McDonald, Ian D Plumb, Robert Rodriguez, Sharon Saydah, Benjamin Slovis, Kari A Stephens, Elizabeth R Unger, Ralph C Wang, Huihui Yu, Bala Hota, Joann G Elmore, Robert A Weinstein, Arjun Venkatesh
BACKGROUND: Long-term symptoms following SARS-CoV-2 infection are a major concern, yet their prevalence is poorly understood. METHODS: We conducted a prospective cohort study comparing adults with SARS-CoV-2 infection (COVID+) with adults who tested negative (COVID-), enrolled within 28 days of an FDA-approved SARS-CoV2 test result for active symptoms. Sociodemographic characteristics, symptoms of SARS-CoV-2 infection (assessed with the CDC Person Under Investigation Symptom List), and symptoms of post-infectious syndromes (i...
December 27, 2022: Clinical Infectious Diseases